Actively Recruiting
Rehabilitation Outcomes Study
Led by UNC Lineberger Comprehensive Cancer Center · Updated on 2026-02-17
60
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This pilot health services interventional study aims to prospectively assess the effectiveness of a pre-treatment rehabilitation (prehabilitation) program across a diverse cohort of adult cancer patients via a randomized pilot trial. Upon screening and identification of high-risk features through a central navigation process, patients referred to oncology clinics will be approached to participate in tailored prehabilitation interventions. The study will track and analyze functional outcomes and quality of life aiming to demonstrate the comprehensive benefits of prehabilitation on the cancer treatment continuum. We hypothesize that this referral program is feasible and that those randomized to the intervention arm will have superior functional outcomes and global health-related quality of life. The rationale for this study is anchored in the urgent need to optimize the cancer care trajectory for high-risk patients whose treatment outcomes and quality of life are jeopardized by the multifaceted challenges of their disease. While prehabilitation has shown potential to mitigate these adverse effects, the optimal methods for identifying and connecting these high-risk individuals to appropriate prehabilitation resources remain underexplored. This study, with its systematic approach to enrolling a diverse adult cancer population, endeavors to investigate not only the benefits of prehabilitation interventions but also the effectiveness of a targeted referral process. By doing so, it aims to uncover novel strategies for efficiently allocating prehabilitation resources, thereby enhancing the precision and impact of supportive cancer care.
CONDITIONS
Official Title
Rehabilitation Outcomes Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Written informed consent and HIPAA authorization provided
- Able and willing to comply with study procedures as judged by the investigator
- Age 18 years or older at time of consent
- Screened by Central Oncology Navigation Program and referred to cancer care at University of North Carolina Medical Center
- Answer yes to at least one of these: health interferes with daily activities, recent falls or unsteadiness, use of medical equipment, or interest in increasing exercise
You will not qualify if you...
- Unable to read and understand English
- Psychological or other disability preventing informed consent
- Unstable medical condition preventing safe exercise participation as judged by investigator
- Prisoners or other institutionalized individuals
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The N.C. Cancer Hospital
Chapel Hill, North Carolina, United States, 27514
Actively Recruiting
Research Team
D
Devin McCarthy
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here